Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3′-diindolylmethane, a major in vivo product of dietary indole-3-carbinol
- 1 September 1999
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 58 (5) , 825-834
- https://doi.org/10.1016/s0006-2952(99)00165-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethaneCarcinogenesis: Integrative Cancer Research, 1998
- Enhancement by indole-3-carbinol of liver and thyroid gland neoplastic development in a rat medium-term multiorgan carcinogenesis modelCarcinogenesis: Integrative Cancer Research, 1997
- Regulation of CYP1A1 by Indolo[3,2-b]carbazole in Murine Hepatoma CellsJournal of Biological Chemistry, 1995
- The anticarcinogen 3,3′-diindolylmethane is an inhibitor of cytochrome P-450Journal of Biochemical Toxicology, 1995
- Inhibitory Effects of the Natural Products Indole‐3‐carbinol and Sinigrin during Initiation and Promotion Phases of 4‐Nitroquinoline 1‐Oxide‐induced Rat Tongue CarcinogenesisJapanese Journal of Cancer Research, 1992
- Oligomerization of indole-3-carbinol in aqueous acidChemical Research in Toxicology, 1992
- Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in miceCarcinogenesis: Integrative Cancer Research, 1991
- Structure elucidation of acid reaction products of indole-3-carbinol: Detection in vivo and enzyme induction in vitroChemico-Biological Interactions, 1991
- A simple phase-extraction assay for chloramphenicol acyltransferase activityGene, 1988
- Inhibition of aflatoxin B1 carcinogenesis in rainbow trout by flavone and indole compoundsCarcinogenesis: Integrative Cancer Research, 1984